GlassScriptPhysician profile
Larry G Ding
NPI 1750325643
$1,650.28
in general payments reported to CMS, 2019-2025
17 companies · $53.87 in 2025
The $53.87 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $141 · 2021: $109 · 2022: $249 · 2023: $218 · 2024: $133 · 2025: $53.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $691.19 | 2019-2025 | |
| Nevro Corp. | $261.57 | 2019 | |
| Sentynl Therapeutics, INC. | $118.80 | 2019 | |
| Collegium Pharmaceutical, INC. | $99.82 | 2019-2022 | |
| Medtronic USA, INC. | $81.99 | 2020 | |
| Scilex Pharmaceuticals INC. | $78.70 | 2019-2020 | |
| Assertio Therapeutics, INC. | $59.82 | 2019 | |
| Kaleo, INC. | $48.68 | 2019 | |
| Daiichi Sankyo INC. | $40.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.27 | 2019 | |
| Trevena, INC. | $29.11 | 2021 | |
| Allergan, INC. | $24.06 | 2022 | |
| Si-Bone, INC. | $22.05 | 2021 | |
| Baudax Bio INC. | $17.51 | 2021 | |
| Pfizer INC. | $16.04 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $15.76 | 2019 | |
| Boston Scientific Corporation | $13.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Ding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.